PEN
Penumbra Inc
NYSE: PEN · HEALTHCARE · MEDICAL DEVICES
$326.48
+0.51% today
Updated 2026-04-30
Market cap
$12.79B
P/E ratio
71.96
P/S ratio
9.11x
EPS (TTM)
$4.53
Dividend yield
—
52W range
$221 – $362
Volume
0.6M
Penumbra Inc (PEN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
12.70%
Operating margin
15.40%
ROE
13.80%
ROA
7.04%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $73.14M | $1.96M | 66.94% | 4.69% | 2.68% |
| 2013 | $88.85M | $4.10M | 65.14% | -1.27% | 4.61% |
| 2014 | $125.51M | $2.25M | 66.00% | 2.40% | 1.79% |
| 2015 | $186.09M | $2.37M | 66.66% | 2.25% | 1.27% |
| 2016 | $263.32M | $14.81M | 64.88% | -0.51% | 5.63% |
| 2017 | $333.76M | $4.66M | 65.06% | 0.35% | 1.40% |
| 2018 | $444.94M | $6.60M | 65.75% | -0.19% | 1.48% |
| 2019 | $547.40M | $48.46M | 67.95% | 8.68% | 8.85% |
| 2020 | $560.41M | $-19.26M | 60.34% | -6.95% | -3.44% |
| 2021 | $747.59M | $2.62M | 63.59% | -1.00% | 0.35% |
| 2022 | $847.13M | $-2.00M | 63.18% | 0.72% | -0.24% |
| 2023 | $1.06B | $90.95M | 64.49% | 6.95% | 8.59% |
| 2024 | $1.19B | $14.01M | 63.20% | 0.78% | 1.17% |
| 2025 | $1.40B | $177.69M | 67.14% | 13.48% | 12.66% |